United StatesDiclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), NDC 76282-103-39, manufactured by DPT Laboratories (307 E Josephine Street, San Antonio, TX) and distributed by Cipla USA, batch XHBG, exp. 08/31/2027, is being recalled nationwide in the U.S. because the product failed pH specifications.
What's being recalled
Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39
Recalling firm: Cipla USA, Inc., Warren, NJ, United States.
How to identify it
Batch XHBG; Exp. 08/31/2027
The hazard
Failed PH Specifications
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide in the USA
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)